| The cost of self-reported penicillin allergy: a systematic review TJ Mattingly II, A Fulton, RA Lumish, AMC Williams, SJ Yoon, M Yuen, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (5), 1649-1654. e4, 2018 | 137 | 2018 |
| Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure C Rhee, K Chiotos, SE Cosgrove, EL Heil, SS Kadri, AC Kalil, DN Gilbert, ... Clinical Infectious Diseases 72 (4), 541-552, 2021 | 133 | 2021 |
| Multicenter study of outcomes with ceftazidime-avibactam in patients with carbapenem-resistant Enterobacteriaceae infections M King, E Heil, S Kuriakose, T Bias, V Huang, C El-Beyrouty, D McCoy, ... Antimicrobial agents and chemotherapy 61 (7), 10.1128/aac. 00449-17, 2017 | 124 | 2017 |
| Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study JC Gallagher, MJ Satlin, A Elabor, N Saraiya, EK McCreary, E Molnar, ... Open forum infectious diseases 5 (11), ofy280, 2018 | 107 | 2018 |
| Considerations for empiric antimicrobial therapy in sepsis and septic shock in an era of antimicrobial resistance JR Strich, EL Heil, H Masur The Journal of Infectious Diseases 222 (Supplement_2), S119-S131, 2020 | 94 | 2020 |
| Dalbavancin use in vulnerable patients receiving outpatient parenteral antibiotic therapy for invasive gram-positive infections JT Bork, EL Heil, S Berry, E Lopes, R Davé, BL Gilliam, A Amoroso Infectious Diseases and Therapy 8, 171-184, 2019 | 94 | 2019 |
| Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria RG D’Angelo, JK Johnson, JT Bork, EL Heil Expert opinion on pharmacotherapy 17 (7), 953-967, 2016 | 91 | 2016 |
| Making the change to area under the curve–based vancomycin dosing EL Heil, KC Claeys, RP Mynatt, TL Hopkins, K Brade, I Watt, MJ Rybak, ... American Journal of Health-System Pharmacy 75 (24), 1986-1995, 2018 | 89 | 2018 |
| Rapid testing using the Verigene Gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against Gram-negative bacteremia JT Bork, S Leekha, EL Heil, LC Zhao, R Badamas, JK Johnson Antimicrobial agents and chemotherapy 59 (3), 1588-1595, 2015 | 85 | 2015 |
| Implementation of an infectious disease fellow-managed penicillin allergy skin testing service EL Heil, JT Bork, SA Schmalzle, M Kleinberg, A Kewalramani, BL Gilliam, ... Open forum infectious diseases 3 (3), ofw155, 2016 | 79 | 2016 |
| New perspectives on antimicrobial agents: cefiderocol EK McCreary, EL Heil, PD Tamma Antimicrobial agents and chemotherapy 65 (8), 10.1128/aac. 02171-20, 2021 | 78 | 2021 |
| Healthcare practitioners’ views of social media as an educational resource AG Pizzuti, KH Patel, EK McCreary, E Heil, CM Bland, E Chinaeke, ... PLoS One 15 (2), e0228372, 2020 | 78 | 2020 |
| Treatment strategies for persistent methicillin‐resistant Staphylococcus aureus bacteraemia PO Lewis, EL Heil, KL Covert, DB Cluck Journal of clinical pharmacy and therapeutics 43 (5), 614-625, 2018 | 75 | 2018 |
| Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections EL Heil, LM Daniels, DM Long, KG Rodino, DJ Weber, MB Miller American Journal of Health-System Pharmacy 69 (21), 1910-1914, 2012 | 73 | 2012 |
| Vancomycin AUC/MIC and corresponding troughs in a pediatric population OA Kishk, AB Lardieri, EL Heil, JA Morgan The Journal of Pediatric Pharmacology and Therapeutics 22 (1), 41-47, 2017 | 64 | 2017 |
| The essential role of pharmacists in antimicrobial stewardship EL Heil, JL Kuti, DT Bearden, JC Gallagher infection control & hospital epidemiology 37 (7), 753-754, 2016 | 58 | 2016 |
| Appropriate antibiotic therapy MG Allison, EL Heil, BD Hayes Emergency Medicine Clinics 35 (1), 25-42, 2017 | 57 | 2017 |
| The essential role of pharmacists in antibiotic stewardship in outpatient care: an official position statement of the Society of Infectious Diseases Pharmacists L Blanchette, T Gauthier, E Heil, M Klepser, KM Kelly, M Nailor, W Wei, ... Journal of the American Pharmacists Association 58 (5), 481-484, 2018 | 53 | 2018 |
| Pharmacodynamic target attainment for cefepime, meropenem, and piperacillin-tazobactam using a pharmacokinetic/pharmacodynamic-based dosing calculator in critically ill patients EL Heil, DP Nicolau, A Farkas, JA Roberts, KA Thom Antimicrobial Agents and Chemotherapy 62 (9), 10.1128/aac. 01008-18, 2018 | 50 | 2018 |
| An antibiotic stewardship program blueprint for optimizing Verigene BC-GN within an institution: a tale of two cities JM Pogue, EL Heil, P Lephart, JK Johnson, RP Mynatt, H Salimnia, ... Antimicrobial Agents and Chemotherapy 62 (5), 10.1128/aac. 02538-17, 2018 | 50 | 2018 |
